Skip to main content
. Author manuscript; available in PMC: 2015 Jan 29.
Published in final edited form as: Gynecol Oncol. 2014 Jan 14;132(3):578–584. doi: 10.1016/j.ygyno.2014.01.007

Table 3.

Multivariable analysis as a function of extrapelvic (hematologic, peritoneal, and lymphatic recurrences beyond the radiation field) disease-free survival in patients with grade 1 and 2 endometrioid endometrial cancera.

Variable No. of patients Univariable analysisHR (95% CI) Multivariable analysisHR (95% CI) P value
FIGO grade .02
  1 15 Reference Reference
  2 33 0.25 (0.08–0.80) 0.25 (0.08–0.80)
Stage b
  IIICo 27 Reference
  IIICab 21 0.41 (0.11–1.54)
Adjuvant chemotherapy
  No 28 Reference
  Yes 18 0.12 (0.02–0.94)

Abbreviations: FIGO, International Federation of Gynecology and Obstetrics; HR, hazard ratio.

a

Only clinicopathologic variables with P < .20 on univariable analysis were considered.

b

Stage: IIICo, positive node(s) only; IIICab, positive node(s) and adnexal involvement, uterine serosal.